CN Patent

CN114621155A — 一种制备卡马替尼的方法

Assigned to Sichuan Kelun Pharmaceutical Research Institute Co Ltd · Expires 2022-06-14 · 4y expired

What this patent protects

本申请公开了化合物4的制备方法以及以化合物4为中间体制备卡马替尼或其药学上可接受的盐的方法，

USPTO Abstract

本申请公开了化合物4的制备方法以及以化合物4为中间体制备卡马替尼或其药学上可接受的盐的方法，

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN114621155A
Jurisdiction: CN
Classification: —
Expires: 2022-06-14
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.